Arvinas, Inc. (ARVN)
7.46
+0.05
(+0.67%)
USD |
NASDAQ |
Oct 05, 16:00
7.46
0.00 (0.00%)
Pre-Market: 09:03
Arvinas Enterprise Value : -72.56M for Oct. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 05, 2026 | -72.56M |
| October 02, 2026 | -75.83M |
| October 01, 2026 | -74.52M |
| September 30, 2026 | -54.60M |
| September 29, 2026 | -69.95M |
| September 28, 2026 | -69.30M |
| September 25, 2026 | -64.07M |
| September 24, 2026 | -51.01M |
| September 23, 2026 | -48.40M |
| September 22, 2026 | -3.997M |
| September 21, 2026 | -17.71M |
| September 18, 2026 | -18.36M |
| September 17, 2026 | -17.06M |
| September 16, 2026 | -26.85M |
| September 15, 2026 | -20.32M |
| September 14, 2026 | -11.18M |
| September 11, 2026 | -7.915M |
| September 10, 2026 | 9.063M |
| September 09, 2026 | 12.33M |
| September 08, 2026 | 33.22M |
| September 04, 2026 | 53.47M |
| September 03, 2026 | 48.24M |
| September 02, 2026 | 66.53M |
| September 01, 2026 | 46.28M |
| August 31, 2026 | 41.06M |
| Date | Value |
|---|---|
| August 28, 2026 | 39.75M |
| August 27, 2026 | 43.67M |
| August 26, 2026 | 48.90M |
| August 25, 2026 | 67.18M |
| August 24, 2026 | 50.20M |
| August 21, 2026 | 51.83M |
| August 20, 2026 | 29.63M |
| August 19, 2026 | 72.40M |
| August 18, 2026 | 44.98M |
| August 17, 2026 | 41.06M |
| August 14, 2026 | 26.04M |
| August 13, 2026 | 28.65M |
| August 12, 2026 | 19.51M |
| August 11, 2026 | 27.35M |
| August 10, 2026 | 27.35M |
| August 07, 2026 | 11.68M |
| August 06, 2026 | 7.104M |
| August 05, 2026 | -11.18M |
| August 04, 2026 | 28.00M |
| August 03, 2026 | -33.38M |
| July 31, 2026 | -35.34M |
| July 30, 2026 | -17.71M |
| July 29, 2026 | -22.93M |
| July 28, 2026 | -24.24M |
| July 27, 2026 | -22.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 14.40M |
| CNBX Pharmaceuticals, Inc. | 1.305M |
| Fulcrum Therapeutics, Inc. | -30.54M |
| Definium Therapeutics, Inc. | 3.821B |
| LeonaBio, Inc. | 2.083M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 169.40M |
| Revenue (Quarterly) | 249.70M |
| Total Expenses (Quarterly) | 80.30M |
| EPS Diluted (Quarterly) | 2.578 |
| Gross Profit Margin (Quarterly) | 95.92% |
| Profit Margin (Quarterly) | 67.84% |
| Earnings Yield | 2.15% |
| Normalized Earnings Yield | 2.933 |